Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with invasive breast cancer, confirmed through a tissue sample (biopsy) and lab testing.
- People whose cancer has spread to a significant number of lymph nodes in the armpit area, as determined by a specific type of CT scan (done lying face down) and an ultrasound scan of the blood vessels.
- People who are suitable for, and have agreed to receive, chemotherapy given before surgery (sometimes called neoadjuvant chemotherapy or NAC).
- People who are suitable for surgery and have agreed to have surgery after completing the pre-surgery chemotherapy.
- People whose pre-surgery chemotherapy treatment plan follows the standard guidelines set by a major cancer organisation called NCCN.
Who may not be able to join:
- People who have a previous history of breast cancer or any other type of cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianyi Jianyi, Master, Cancer Hospital of China Medical University, Liaoning Cancer Hospital
Phone: 8618940257177
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
post-surgery pathology concordance rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.